Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential-Reference-Cited by-同舟云学术

Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential

Published:2021-10-06 Issue:22 Volume:25 Page:10376-10388
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Naik Adviti¹,Thomas Remy¹,Al‐Khadairi Ghaneya¹²,Bacha Rim¹²,Hendrickx Wouter²³,Decock Julie¹²^ORCID

Affiliation:

1. Translational Cancer and Immunity Center Qatar Biomedical Research Institute (QBRI) Hamad Bin Khalifa University (HBKU) Qatar Foundation (QF) Doha Qatar

2. College of Health and Life Sciences (CHLS) Hamad Bin Khalifa University (HBKU) Qatar Foundation (QF) Doha Qatar

3. Cancer Department, Research Branch Sidra Medicine Doha Qatar

Funder

Qatar National Research Fund

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16967

Reference48 articles.

1. Hypomethylation ofPRAMEis responsible for its aberrant overexpression in human malignancies

2. Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor

3. A Causal Role for the Human Tumor Antigen Preferentially Expressed Antigen of Melanoma in Cancer

4. Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia

5. Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A panel of cancer testis antigens in pan squamous cell carcinomas: implication for biomarkers and therapeutic targets;2024-05-23

2. Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer;Molecular Therapy: Oncology;2024-03

3. PRAME Updated: Diagnostic, Prognostic, and Therapeutic Role in Skin Cancer;International Journal of Molecular Sciences;2024-01-27

4. PRAME/MELAN-A double immunostaining as a diagnostic tool for conjunctival melanocytic lesions: A South American experience;Pathology - Research and Practice;2023-10

5. Preferentially Expressed Antigen in Melanoma Is a Multifaceted Cancer Testis Antigen with Diverse Roles as a Biomarker and Therapeutic Target;International Journal of Translational Medicine;2023-08-29